Profile

    Corporate information

    Official name
    Maridose LLC

    Registration country
    Investment activity status
    Active investor

    Company type

    Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.

    Overview

    Maridose in collaboration with Israel’s medical marijuana pioneer Tikun-Olam has been approved by the US Drug Enforcement Administration (DEA) to be a Schedule 1 drug manufacturer licensed to cultivate marijuana for research and commercial product development purposes. Our research/cultivation facility and Center of Excellence for Cannabis Research is located at Brunswick Landing in Brunswick, Maine. Unlike the approximately 600 Schedule 1 cannabis “researchers”, our license allows us to legally research the live plant.

    Funding rounds

    Pre Seed USD 150,000


    USD 150,000 (1 Jan 2021)